MARC record from Internet Archive

LEADER: 02875nam a22006257a 4500
001 2006502784
003 DLC
005 20080422192440.0
008 061218s2006 fr a b i101 0 eng
010 $a 2006502784
016 7 $a101290223$2DNLM
020 $a9789283212867
020 $a928321286X
035 $a(OCoLC)ocm70866265
040 $aNLM$cNLM$dCUD$dCOU$dVAM$dBAKER$dYDXCP$dLVB$dNLGGC$dBTCTA$dDLC
042 $anlmcopyc$alccopycat
050 00 $aRC268.6$b.C63 2006
060 00 $aW1$bIA21I v.86 2006
060 10 $aQZ 202$bC652 2006
084 $a44.81$2bcl
245 00 $aCobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide, and vanadium pentoxide /$cIARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
260 $aLyon, France :$bInternational Agency for Research on Cancer ;$aGeneva, Switzerland :$bDistributed by WHO Press,$c2006.
300 $axiv, 330 p. :$bill.
440 0 $aIARC monographs on the evaluation of carcinogenic risks to humans,$x1017-1606 ;$vv. 86
500 $a"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 October 2003."
500 $aAt head of title: World Health Organization, International Agency for Research on Cancer.
504 $aIncludes bibliographical references and index.
505 2 $aMetallic cobalt particles (with or without tungsten carbide) -- Introduction to the monographs on gallium arsenide and indium phosphide. Studies of cancer in humans -- Gallium arsenide -- Indium phosphide -- Vanadium pentoxide.
650 12 $aCarcinogenicity Tests$vCongresses.
650 12 $aCarcinogens$xtoxicity$vCongresses.
650 22 $aCobalt$xadverse effects$vCongresses.
650 22 $aGallium$xadverse effects$vCongresses.
650 22 $aIndium$xadverse effects$vCongresses.
650 22 $aRisk Assessment$vCongresses.
650 22 $aVanadium Compounds$xadverse effects$vCongresses.
650 0 $aCarcinogens.
650 0 $aCobalt$xPhysiological effect.
650 0 $aArsenic$xHealth aspects.
650 0 $aIndium.
650 0 $aGallium.
650 0 $aVanadium compounds.
650 0 $aTungsten.
650 6 $aCancérogènes.
650 6 $aCobalt$xEffets physiologiques.
650 6 $aArsenic$xAspect sanitaire.
650 6 $aIndium.
650 6 $aGallium.
650 6 $aVanadium$xComposés.
650 6 $aTungstène.
650 17 $aZware metalen.$2gtt
650 17 $aCarcinogeniteit.$2gtt
710 2 $aWorld Health Organization.
710 2 $aInternational Agency for Research on Cancer.
711 2 $aIARC Working Group on the Evaluation of Carcinogenic Risks to Humans$d(2003 Oct. 7-14 :$cLyon, France)
856 42 $uhttp://monographs.iarc.fr/ENG/Monographs/vol86/volume86.pdf$zConnect to free summary and evaluation online.